Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-008056
Filing Date
2023-03-15
Accepted
2023-03-15 14:51:57
Documents
205
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F adc-20221231.htm   iXBRL 20-F 4340277
2 EX-1.1 exhibit11articlesofassocia.htm EX-1.1 426800
3 EX-2.2 exhibit21descriptionofsecu.htm EX-2.2 172109
4 EX-4.9 exhibit49adct-sobixlicense.htm EX-4.9 1020304
5 EX-12.1 ex121-ceocertification3021.htm EX-12.1 10019
6 EX-12.2 ex122-cfocertification3021.htm EX-12.2 10337
7 EX-13.1 ex131-ceocertification9061.htm EX-13.1 4900
8 EX-13.2 ex132-cfocertification9061.htm EX-13.2 4997
9 EX-15.1 exhibit151adct-consent20xf.htm EX-15.1 2008
15 adc-20221231_g1.jpg GRAPHIC 68341
16 adc-20221231_g10.jpg GRAPHIC 130072
17 adc-20221231_g11.jpg GRAPHIC 116152
18 adc-20221231_g12.jpg GRAPHIC 35136
19 adc-20221231_g13.jpg GRAPHIC 50719
20 adc-20221231_g14.jpg GRAPHIC 34126
21 adc-20221231_g15.jpg GRAPHIC 38111
22 adc-20221231_g16.jpg GRAPHIC 767668
23 adc-20221231_g17.jpg GRAPHIC 765031
24 adc-20221231_g18.jpg GRAPHIC 32976
25 adc-20221231_g19.jpg GRAPHIC 67364
26 adc-20221231_g2.jpg GRAPHIC 402415
27 adc-20221231_g20.jpg GRAPHIC 87313
28 adc-20221231_g21.jpg GRAPHIC 24042
29 adc-20221231_g22.jpg GRAPHIC 21315
30 adc-20221231_g23.jpg GRAPHIC 32718
31 adc-20221231_g24.jpg GRAPHIC 20927
32 adc-20221231_g25.jpg GRAPHIC 76336
33 adc-20221231_g26.jpg GRAPHIC 26753
34 adc-20221231_g27.jpg GRAPHIC 57365
35 adc-20221231_g28.jpg GRAPHIC 48950
36 adc-20221231_g29.jpg GRAPHIC 29619
37 adc-20221231_g3.jpg GRAPHIC 80485
38 adc-20221231_g4.jpg GRAPHIC 173626
39 adc-20221231_g5.jpg GRAPHIC 23384
40 adc-20221231_g6.jpg GRAPHIC 165176
41 adc-20221231_g7.jpg GRAPHIC 38966
42 adc-20221231_g8.jpg GRAPHIC 101055
43 adc-20221231_g9.jpg GRAPHIC 64875
  Complete submission text file 0001628280-23-008056.txt   31088271

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adc-20221231.xsd EX-101.SCH 213638
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adc-20221231_cal.xml EX-101.CAL 127370
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adc-20221231_def.xml EX-101.DEF 889066
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adc-20221231_lab.xml EX-101.LAB 1548570
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adc-20221231_pre.xml EX-101.PRE 1141543
199 EXTRACTED XBRL INSTANCE DOCUMENT adc-20221231_htm.xml XML 3752740
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39071 | Film No.: 23734722
SIC: 2834 Pharmaceutical Preparations